SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-035121
Filing Date
2020-02-13
Accepted
2020-02-13 13:28:26
Documents
1
Group Members
ALLIANZ GLOBAL INVESTORS U.S. LLC

Document Format Files

Seq Description Document Type Size
1 ASSERTIO THERAPEUTICS, INC. d883233dsc13g.htm SC 13G 81168
  Complete submission text file 0001193125-20-035121.txt   82794
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Subject) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-53683 | Film No.: 20608781
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address 1633 BROADWAY NEW YORK NY 10019 212-739-3000
Allianz Global Investors U.S. Holdings LLC (Filed by) CIK: 0001567940 (see all company filings)

IRS No.: 330977088 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G